“Phase II Trial of Romidepsin (FK228 or Depsipeptide) in Peripheral T-Cell Lymphoma: Clinical Activity and Molecular Markers”. Hematology Meeting Reports, vol. 2, no. 13, June 2009, https://doi.org/10.4081/hmr.v2i13.482.